Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review

November 2021 | 38 pages | ID: ZD4A064F0E2EN
GlobalData

Abstracts

Zenotech Laboratories Ltd (532039) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Zenotech Laboratories Ltd (Zenotech Laboratories), a subsidiary of Sun Pharmaceutical Industries Ltd that manufactures and markets specialty pharmaceutical and biotechnology products. The company's products include granulocyte-macrophage colony-stimulating factor (GMCSF) and granulocyte-colony stimulating factor (GCSF). It also offers contract manufacturing services for generic cancer, biopharmaceutical and generic anesthetic injectables. It has subsidiaries in Brazil and the US. Zenotech Laboratories is headquartered in Hyderabad, Telangana, India.

Zenotech Laboratories Ltd Key Recent Developments

Oct 22,2021: Zenotech Laboratories Announces Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2021
Jul 24,2021: Zenotech Laboratories announce Approval Of Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2021
Jan 23,2021: Zenotech announces appointment of chief executive officer of the company
Jan 23,2021: Zenotech Laboratories Announces Statement of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020
Aug 14,2020: Zenotech Laboratories: cease of Chief Executive Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Zenotech Laboratories Ltd - Key Facts
Zenotech Laboratories Ltd - Key Employees
Zenotech Laboratories Ltd - Major Products and Services
Zenotech Laboratories Ltd - History
Zenotech Laboratories Ltd - Company Statement
Zenotech Laboratories Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Zenotech Laboratories Ltd - Business Description
Zenotech Laboratories Ltd - Corporate Strategy
Zenotech Laboratories Ltd - SWOT Analysis
SWOT Analysis - Overview
Zenotech Laboratories Ltd - Strengths
Zenotech Laboratories Ltd - Weaknesses
Zenotech Laboratories Ltd - Opportunities
Zenotech Laboratories Ltd - Threats
Zenotech Laboratories Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Zenotech Laboratories Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 22, 2021: Zenotech Laboratories Announces Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2021
Jul 24, 2021: Zenotech Laboratories announce Approval Of Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2021
Jan 23, 2021: Zenotech announces appointment of chief executive officer of the company
Jan 23, 2021: Zenotech Laboratories Announces Statement of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020
Aug 14, 2020: Zenotech Laboratories: cease of Chief Executive Officer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Zenotech Laboratories Ltd, Key Facts
Zenotech Laboratories Ltd, Key Employees
Zenotech Laboratories Ltd, Major Products and Services
Zenotech Laboratories Ltd, History
Zenotech Laboratories Ltd, Subsidiaries
Zenotech Laboratories Ltd, Key Competitors
Zenotech Laboratories Ltd, Ratios based on current share price
Zenotech Laboratories Ltd, Annual Ratios
Zenotech Laboratories Ltd, Annual Ratios (Cont...1)
Zenotech Laboratories Ltd, Annual Ratios (Cont...2)
Zenotech Laboratories Ltd, Interim Ratios
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Zenotech Laboratories Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Zenotech Laboratories Ltd, Performance Chart (2017 - 2021)
Zenotech Laboratories Ltd, Ratio Charts
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021